Tongling Group: Controlling shareholders are planning to change from Shangkun Biotech to Shangkun Consultation.
Tongling Corporation announced on September 15, 2025, Shangkun Biotechnology and Shangkun Consulting signed a "Share Transfer Agreement". According to the agreement, Shangkun Biotechnology will transfer all of its 29.08% stake in the company to Shangkun Consulting. Shangkun Biotechnology will no longer hold any shares in the company, and the controlling shareholder will change from Shangkun Biotechnology to Shangkun Consulting.
Latest